Figure 1
From: The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
Alzheimer’s disease (AD) biomarkers in the cohort. To demonstrate that the cohort had typical AD biomarker patterns, the levels of CSF Aβ42, T-tau, and P-tau S199 were compared between the two groups. Aβ42 levels were significantly lower in the amyloid-positive group than those in the amyloid-negative group (a). The cerebrospinal fluid (CSF) P-tau S199 (b) and T-tau (c) levels were significantly higher in the amyloid-positive group than those in the amyloid-negative group. Statistical analysis was performed using the Mann–Whitney test. sTREM2 soluble triggering-receptor expressed on myeloid cells 2, NfL neurofilament light chain, NRGN neurogranin. Statistical significance *P < 0.05, **P < 0.01.
